| Literature DB >> 29339211 |
Chang Li1, Liang Wan2, Zeyi Liu3, Guangquan Xu4, Shengjie Wang5, Zhiyue Su2, Yingxi Zhang2, Cuijuan Zhang2, Xia Liu2, Zhe Lei6, Hong-Tao Zhang7.
Abstract
Growing evidence shows that lncRNA XIST functions as an oncogene accelerating tumor progression. Transforming growth factor β (TGF-β)-induced epithelial-mesenchymal transition (EMT) plays a key role in tumor metastasis. However, it is still unclear whether lncRNA XIST is implicated in TGF-β-induced EMT and influences cell invasion and metastasis in non-small-cell lung cancer (NSCLC). Here, we observed increased expression of lncRNA XIST and ZEB2 mRNA in metastatic NSCLC tissues. Knockdown of lncRNA XIST inhibited ZEB2 expression, and repressed TGF-β-induced EMT and NSCLC cell migration and invasion. Being in consistent with the in vitro findings, the in vivo experiment of metastasis showed that knockdown of lncRNA XIST inhibited pulmonary metastasis of NSCLC cells in mice. In addition, knockdown of ZEB2 expression can inhibit TGF-β-induced EMT and NSCLC cell migration and invasion. Mechanistically, lncRNA XIST and ZEB2 were targets of miR-367 and miR-141. Furthermore, both miR-367 and miR-141 expression can be upregulated by knockdown of lncRNA XIST. Taken together, our study reveals that lncRNA XIST can promote TGF-β-induced EMT and cell invasion and metastasis by regulating miR-367/miR-141-ZEB2 axis in NSCLC.Entities:
Keywords: EMT; Non-small-cell lung cancer (NSCLC); Transforming growth factor beta (TGF-β); lncRNA XIST; miR-141
Mesh:
Substances:
Year: 2018 PMID: 29339211 DOI: 10.1016/j.canlet.2018.01.036
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679